ERBB2 and breast cancer: Because the SLC4A7 mRNA level—based on the abovementioned considerations—does not reflect the NBCn1 protein level or functional capacity in HER2-enriched breast cancer, the survival analysis based on SLC4A7 mRNA expression (Figure 10F) should be interpreted with caution for this molecular subtype.